Post by Fortrea

New FDA guidance is opening the door to a smarter, faster path for genome-edited gene therapy development. In our latest blog by Sanjay Jain, PhD, MBA, Fortrea’s experts explore how sponsors can leverage prior knowledge to streamline development while maintaining scientific rigor. The result? Greater efficiency, reduced duplication, and the potential to bring transformative therapies to patients faster. 🔗 https://lnkd.in/eTDv_rVS #GeneTherapy #GenomeEditing #CellAndGeneTherapy #ClinicalDevelopment #Biotech